Latest News

Puzzling Preliminary Results Announced for Viltolarsen’s Confirmatory Trial in Duchenne Muscular Dystrophy
Puzzling Preliminary Results Announced for Viltolarsen’s Confirmatory Trial in Duchenne Muscular Dystrophy

May 28th 2024

Following the mixed results, NS Pharma is working with the FDA to determine how to proceed with viltolarsen.

Gaining Clinical Insights Into the Benefits of Subcutaneous Ocrelizumab
Gaining Clinical Insights Into the Benefits of Subcutaneous Ocrelizumab

May 28th 2024

Dennis Podlesak  (Credit: Transposon)
Transposon Therapeutics’ TPN-101 for Progressive Supranuclear Palsy Gets Fast Tracked

May 28th 2024

Merit Cudkcowitz MD, MSc  (Credit: Massachusetts General Hospital)
NeurologyLive® Clinician of the Month Spotlight: Merit Cudkowicz, MD, MSc

May 28th 2024

Safety Concerns Arise Amid Andexanet’s Superior Performance in Hematoma Expansion Resolution
Safety Concerns Arise Amid Andexanet’s Superior Performance in Hematoma Expansion Resolution

May 27th 2024

Coverage of the 2024 American Academy of Neurology Annual Meeting

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor of the AAN Annual Meeting.

AAN 2024

Conference Coverage

View All
Gaining Clinical Insights Into the Benefits of Subcutaneous Ocrelizumab
Gaining Clinical Insights Into the Benefits of Subcutaneous Ocrelizumab

May 28th 2024

Post-AAN Perspectives: Recapping Major Areas of Growth in Neurology
Post-AAN Perspectives: Recapping Major Areas of Growth in Neurology

May 23rd 2024

NeuroVoices: Katherine Peters, PhD, on Vorasidenib’s Impact on Quality of Life, Neurocognition, and Seizures in the Treatment of Gliomas
NeuroVoices: Katherine Peters, PhD, on Vorasidenib’s Impact on Quality of Life, Neurocognition, and Seizures in the Treatment of Gliomas

May 22nd 2024

Frederic Schaper, MD, PhD  (Credit: Harvard Catalyst)
Exploring the Association Between Brain Lesions and Takotsubo Syndrome

May 21st 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.